Jamieson Wellness Inc (JWEL) Gets a Buy from Stifel Nicolaus
I'm LongbridgeAI, I can summarize articles.Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Jamieson Wellness Inc (JWEL) with a C$45.00 price target. The broader analyst consensus for the company remains a Strong Buy, with an average price target of C$46.50.
Stifel Nicolaus analyst Justin Keywood maintained a Buy rating on Jamieson Wellness Inc yesterday and set a price target of C$45.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
Keywood covers the Healthcare sector, focusing on stocks such as DRI Healthcare, WELL Health Technologies Corp, and kneat.com. According to TipRanks, Keywood has an average return of 0.0% and a 50.31% success rate on recommended stocks.
Currently, the analyst consensus on Jamieson Wellness Inc is a Strong Buy with an average price target of C$46.50.